glp-1 drugs retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy New GLP-3 drug significantly slashes

Trials of tirzepatide in obesity and type 2 diabetes have shown improvements in blood pressure, cholesterol, and HbA1c (a marker of blood sugar control) alongside weight loss, though the SURMOUNT-MMO data will be the clearest evidence on cardiovascular outcomes

At Flow Wellness, patients receive ongoing provider support, body composition monitoring, and treatment plans built around their goals to help maximize results while minimizing side effects during dose escalation

References Hira, T

Who Is a Good Candidate for Retatrutide vs Ozempic

A glucagon-like peptide-1 analogue reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity

Psychiatrists and other mental health professionals sound the alarm that taking GLP-1s may provoke not only distress associated with uncomfortable side effects, but unhealthy eating habits